Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by 4real4everon Aug 11, 2021 11:53am
83 Views
Post# 33685018

$0,41 (yo gogo)

$0,41 (yo gogo)
August 07, 2021 - 04:04 PM
124 Reads
Post# 33668689

Bashers' posts misleading 'cause nobody can be that stupid.

It's clear from the bashers' posts that their agenda is to mislead.
Most of the "questions" asked can be answered by the advent of the Covid crisis... which is great news, because...it's over!
And all that potential energy in backlogged contracts will be showing up as REVENUES this year!
Some of the "questions" are outright LIES, like the assertion that Clarus downgraded the price target by $4.00.
Not true.
The price target was $4.00 and is now ... $1.25!
That's over three times the current price!
Even bashers' lies tell you that this is a great buy.
Twit even posted a meme showing Pawn Stars' Rick Harrison saying, "I'll give you five bucks for it."!
Says it all! lol
This stock will be worth $5.00 by 2023! And that's only 18 months away! And with all this potential energy, it could even happen before...
GLTA!


4real4erver wrote:

August 07, 2021 - 01:00 PM
152 Reads
Post# 33668436

Funny how pumpers can't answer simple questions

1. How many sale of Aristotle?
2. How many sale from Oncore Pharma?
3. Why they do the consolidation 1 year ago?
4. Where is the Large healthcare/firefighters/UPMC/Oncore Pharma/2000 tests per month
5. How much revenue from ColonSentry + BreastSentry + prostate in 2020 & 2021?
6. Why the share price is at $0,43 (or $0,05) today?
7. Why the OTC listing doesn't change anything on the share price?
8. Why the last 3 Investor Summit doesn't bring money?
9. Why Clarus cut the target by 4?
10. Why they done 3-4 PP in the last 2-3- years?


When you know the answer of these questions and you are able to admit/tell them, you know what SZLS is worth.

Will any of the pumpers here have the balls to answer these questions?



<< Previous
Bullboard Posts
Next >>